LIVN|LivaNova PLC|Price:65.930|Chg%:-0.83

More Details of LivaNova PLC Company

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.

LivaNova PLC Info



Ticker SymbolLIVN

Company nameLivaNova PLC

IPO dateOct 19, 2015

CEOMakatsaria (Vladimir A)

Number of employees2900

Security typeOrdinary Share

Fiscal year-endOct 19

Address20 Eastbourne Terrace

CityLONDON

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited Kingdom

Postal codeW2 6LG

Phone442033250662

Websitehttps://www.livanova.com/

Ticker SymbolLIVN

IPO dateOct 19, 2015

CEOMakatsaria (Vladimir A)

Company Executives of LivaNova PLC



Name

Name/Position

Position

Shareholding

Change

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+4259.00%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

--

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

--

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+1810.00%

Franco Poletti ,

President, Cardiopulmonary Business Unit

9.07K

+551.00%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+3006.00%

Mr. Francesco Bianchi

Independent Director

9.03K

-1500.00%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

6.80K

+1132.00%

Ms. Brooke Story

Independent Director

6.23K

-250.00%

Ms. Susan M. Podlogar

Independent Director

2.09K

+2086.00%

Name

Name/Position

Position

Shareholding

Change

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+4259.00%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

--

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

--

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+1810.00%

Franco Poletti ,

President, Cardiopulmonary Business Unit

9.07K

+551.00%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+3006.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Relevant data have not been disclosed by the company yet.

By RegionUSD

Name

Revenue

Proportion

United States

190.45M

53.23%

Rest of World

99.62M

27.85%

Europe

67.68M

18.92%

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Nov 16

Shareholders

Shareholder Types

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

11.60%

PRIMECAP Management Company

8.14%

Millennium Management LLC

5.44%

Artisan Partners Limited Partnership

4.44%

Wellington Management Company, LLP

4.30%

Other

66.08%

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

11.60%

PRIMECAP Management Company

8.14%

Millennium Management LLC

5.44%

Artisan Partners Limited Partnership

4.44%

Wellington Management Company, LLP

4.30%

Other

66.08%

Shareholder Types

Shareholders

Proportion

Investment Advisor

50.08%

Investment Advisor/Hedge Fund

36.00%

Hedge Fund

13.06%

Research Firm

3.21%

Pension Fund

2.27%

Bank and Trust

1.31%

Individual Investor

0.37%

Sovereign Wealth Fund

0.09%

Insurance Company

0.03%

Institutional Shareholding



Updated: Thu, Jan 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

570

57.85M

105.93%

-10.56M

2025Q3

562

56.86M

104.13%

-8.50M

2025Q2

564

56.85M

104.11%

-6.95M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Institutional Trust Company, N.A.

6.34M

11.6%

-38.63K

-0.61%

Sep 30, 2025

PRIMECAP Management Company

4.44M

8.14%

-196.52K

-4.23%

Sep 30, 2025

Millennium Management LLC

2.97M

5.44%

+544.03K

+22.43%

Sep 30, 2025

Artisan Partners Limited Partnership

2.43M

4.44%

+1.18M

+94.54%

Sep 30, 2025

Wellington Management Company, LLP

2.35M

4.3%

+1.07M

+83.51%

Sep 30, 2025

The Vanguard Group, Inc.

2.28M

4.18%

-157.70K

-6.46%

Sep 30, 2025

State Street Investment Management (US)

2.06M

3.76%

-25.71K

-1.24%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.72M

3.15%

+106.89K

+6.62%

Sep 30, 2025

AQR Capital Management, LLC

1.66M

3.04%

-390.84K

-19.07%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.45M

2.65%

+16.35K

+1.14%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

State Street SPDR S&P Health Care Equipment ETF

1.66%

JPMorgan Active Small Cap Value ETF

1.43%

Invesco NASDAQ Future Gen 200 ETF

0.5%

Simplify Health Care ETF

0.43%

Global X Aging Population ETF

0.42%

JPMorgan Fundamental Data Science Small Core ETF

0.37%

Avantis US Small Cap Equity ETF

0.34%

iShares U.S. Medical Devices ETF

0.34%

WisdomTree US SmallCap Fund

0.33%

Federated Hermes MDT Small Cap Core ETF

0.33%

State Street SPDR S&P Health Care Equipment ETF

Proportion1.66%

JPMorgan Active Small Cap Value ETF

Proportion1.43%

Invesco NASDAQ Future Gen 200 ETF

Proportion0.5%

Simplify Health Care ETF

Proportion0.43%

Global X Aging Population ETF

Proportion0.42%

JPMorgan Fundamental Data Science Small Core ETF

Proportion0.37%

Avantis US Small Cap Equity ETF

Proportion0.34%

iShares U.S. Medical Devices ETF

Proportion0.34%

WisdomTree US SmallCap Fund

Proportion0.33%

Federated Hermes MDT Small Cap Core ETF

Proportion0.33%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data